CSIMarket
 
Vivos Therapeutics Inc   (NASDAQ: VVOS)
Other Ticker:  
 
 
Price: $2.8000 $0.32 12.903%
Day's High: $2.9 Week Perf: 31.46 %
Day's Low: $ 2.55 30 Day Perf: 21.21 %
Volume (M): 502 52 Wk High: $ 6.28
Volume (M$): $ 1,406 52 Wk Avg: $3.07
Open: $2.70 52 Wk Low: $1.97



 Market Capitalization (Millions $) 14
 Shares Outstanding (Millions) 5
 Employees 50
 Revenues (TTM) (Millions $) 15
 Net Income (TTM) (Millions $) -11
 Cash Flow (TTM) (Millions $) 5
 Capital Exp. (TTM) (Millions $) 1

Vivos Therapeutics Inc
Vivos Therapeutics Inc is a medical technology company that specializes in treating obstructive sleep apnea (OSA) and other sleep-disordered breathing conditions. The company has developed a unique treatment approach called the Vivos System, which focuses on non-surgical, non-pharmaceutical methods to address the underlying causes of sleep apnea.

The Vivos System aims to remodel and enhance the patient's upper airway through the use of proprietary oral appliances. These appliances are custom-designed based on each individual's unique anatomy and are intended to widen the upper airway, leading to improved breathing during sleep.

The company's treatment approach is grounded in the concept of craniofacial growth and development, recognizing that deficiencies in facial and airway structures can contribute to sleep-disordered breathing. By utilizing a multidisciplinary approach involving dentists, orthodontists, and physicians, Vivos Therapeutics seeks to provide a comprehensive treatment solution for patients with sleep apnea.

Vivos Therapeutics Inc aims to address the significant unmet need for alternative treatments to the standard continuous positive airway pressure (CPAP) therapy, which can be cumbersome and uncomfortable for some patients. The company's technology has shown promise in clinical studies, with patients reporting significant improvements in sleep quality and reduction in sleep apnea symptoms.

In summary, Vivos Therapeutics Inc is a medical technology company that offers a unique non-surgical treatment approach for obstructive sleep apnea, focusing on enhancing the upper airway through custom-designed oral appliances.


   Company Address: 7921 Southpark Plaza Littleton 80120 CO
   Company Phone Number: 672-4357   Stock Exchange / Ticker: NASDAQ VVOS


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
RDGL        3.11% 
RMD        1.74% 
HUN   -5.69%    
SNBR        1.41% 
• View Complete Report
   



Contract

Vivos Therapeutics Signs Definitive Agreement to Acquire Nevadas Largest Sleep Center Operator, Eyes Market Growth A...

Published Wed, Apr 16 2025 12:47 PM UTC

Vivos Therapeutics Moves to Expand Reach with Acquisition of Largest Sleep Center Operator in Nevada Las Vegas, NV Vivos Therapeutics Inc. (NASDAQ: VVOS) has announced a definitive agreement to acquire the largest sleep center operator in Nevada, marking a significant strategic move for the company as it aims to consolidate its presence in the growing sleep disorder trea...

Product Service News

Vivos Therapeutics Pioneering the Future of Obstructive Sleep Apnea Treatment with CPT Coverage, Medicare Reimburse...

Published Tue, Oct 8 2024 11:30 AM UTC

In a pivotal advancement for the treatment of obstructive sleep apnea (OSA), Vivos Therapeutics has been granted new Current Procedural Terminology (CPT) coverage and reimbursement codes by the American Medical Association for its flagship Vivos CARE oral medical devices. This development is expected to significantly streamline the billing process for commercial payers, ulti...

Shares

Vivos Therapeutics Secures Funding Through Direct Offering to Propel Growth in Sleep Disorder Treatments

Published Thu, Sep 19 2024 11:00 AM UTC

Analyzing Vivos Therapeutics Strategic Move: A New Offering and Its Implications for ShareholdersVivos Therapeutics, Inc. (NASDAQ: VVOS), based in Littleton, Colorado, has recently announced a definitive agreement with institutional investors to raise capital through the issuance of 1,363,812 shares of its common stock at a purchase price of $3.15 per share. This registere...

Product Service News

?Vivos Therapeutics Secures FDA Clearance for Pediatric Sleep Apnea Treatment, Revamping Care for Childr...

Published Wed, Sep 18 2024 11:00 AM UTC

In a landmark moment for pediatric healthcare, Vivos Therapeutics has announced that it has received FDA 510(k) clearance to market its innovative sleep apnea treatment solutions aimed at addressing moderate to severe obstructive sleep apnea (OSA) in children. This pivotal regulatory approval not only marks a significant achievement for the company but also positions it to d...

Financing Agreement

Vivos Therapeutics: Pioneering Sleep Treatment Through Strategic Alliances and Private Equity Investment

Published Wed, Jun 12 2024 11:30 AM UTC

Vivos Therapeutics: Revolutionizing Sleep Treatment with Strategic Alliance and Private Equity Investment
In a critical pivot towards enhancing revenue streams and potential profit, Vivos Therapeutics recently announced the closure of a momentous $7.5 million At-The-Market private equity-backed investment. Coupled with this exciting development, the leading sleep treatme...







Vivos Therapeutics Inc's Segments
Appliances    47.48 % of total Revenue
Guides    11.25 % of total Revenue
Product    58.73 % of total Revenue
VIP    27.77 % of total Revenue
Billing Intelligence Services    6.18 % of total Revenue
Sleep Testing Services    9.87 % of total Revenue
Myofunctional Therapy Services    4.41 % of total Revenue
Sponsorship Seminar Other    8.82 % of total Revenue
Service    57.05 % of total Revenue





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com